C47: Rodent Behavioral and Antidepressant Effects of Psilocybin and Novel Tryptamines

Clinical trials on the use of psilocybin to treat depression are promising, but still in preliminary stages. Additionally, they are confounded by the presence of hallucinations, which may not be necessary for its clinical effectiveness but create significant challenges in experimental design. Thus, there is a need to determine if other tryptamines have similar molecular […]

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top